Pricing project for innovative pre-FDA 510(k) at-home dermatology device

Our organization will be selling an innovative therapeutic device directly to patients who suffer from dermatological autoimmune conditions (a target market of about 40 million patients, with a beachhead market of 6.5M patients, a segment of which we are directly targeting approximately 2.5M). Through an online patient portal on which there are 85,000 frustrated patients, we would like to conduct a pricing study to reach our target segment. Because this purchase decision will be made by patients, we are not interested in WTP of physicians or payers.